Changan Capital

Chang'an Capital (also stylised Changan Private Capital) is a Beijing, China-based investment firm focused on venture capital and private equity investments in value-creating companies across multiple sectors, with particular activity in biotechnology, healthcare, robotics, and advanced manufacturing. The firm operates from No. 23, Xihaibeiyan, Xicheng, Beijing, invests primarily in Chinese startups and growth-stage companies, and has a portfolio of more than 50 companies and a team of approximately seven investment professionals. Disclosed portfolio investments include ProfoundBio, Aibo Medical, White Rhino (autonomous driving), Renjing Biotech, Ningxia Golden Silicon, and Woby Medical, and the firm frequently co-invests alongside institutions such as CDH Investments, Lilly Asia Ventures, Sequoia Capital China, and Banyan Capital. Chang'an Capital operates as a mid-sized Chinese institutional venture and private equity investor within the broader Chinese innovation ecosystem.